Sortilin, Encoded by the Cardiovascular Risk Gene SORT1, and Its Suggested Functions in Cardiovascular Disease

Current Atherosclerosis Reports

Volumn 17, Issue 4, 2015, Pages

  Kjolby, Mads ^a,b,c,d   Nielsen, Morten Schallburg ^a   Petersen, Claus Munck ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b DANISH DIABETES ACADEMY   (Denmark)

^c Nordic EMBL Partnership for Molecular Medicine   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

IL6; LDL cholesterol; PCSK9; SORT1; Sortilin; TNF

Indexed keywords

INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; SORTILIN; TUMOR NECROSIS FACTOR ALPHA; IL6 PROTEIN, HUMAN; PCSK9 PROTEIN, HUMAN; SERINE PROTEINASE; VERY LOW DENSITY LIPOPROTEIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ABDOMINAL AORTA ANEURYSM; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHROMOSOME; CHROMOSOME 1P13.3; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY OBSTRUCTION; CORRELATIONAL STUDY; DISEASE ASSOCIATION; GENE LOCUS; GENETIC ASSOCIATION; HEART INFARCTION; HUMAN; LIPID DIET; LIPID METABOLISM; LIVER METABOLISM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SORT1 GENE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; GENETICS; IMMUNOLOGY; METABOLISM; SECRETION (PROCESS);

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERLEUKIN-6; LIPID METABOLISM; LIPOPROTEINS, VLDL; PROPROTEIN CONVERTASES; SERINE ENDOPEPTIDASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923844366     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-015-0496-7     Document Type: Review

References (68)

1. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol. 2004;160:407–20.
2. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707–13.
3. Petersen CM, Nielsen MS, Nykjaer A, Jacobsen L, Tommerup N, Rasmussen HH, et al. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem. 1997;272:3599–605.
4. Tissir F, Qu Y, Montcouquiol M, Zhou L, Komatsu K, Shi D, et al. Lack of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal hydrocephalus. Nat Neurosci. 2010;13:700–7.
5. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40:189–97.
6. Kjolby M, Andersen OM, Breiderhoff T, Fjorback AW, Pedersen KM, Madsen P, et al. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab. 2010;12:213–23.
7. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466:714–9.
8. Gustafsen C, Kjolby M, Nyegaard M, Mattheisen M, Lundhede J, Buttenschøn H, et al. The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion. Cell Metab. 2014;19:310–8. The first paper to show that sortilin facilitates secretion of PCSK9, and that this affects the liver LDLR expression.
9. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–53.
10. Sandhu MS, Waterworth DM, Debenham SL, Wheeler E, Papadakis K, Zhao JH, et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet. 2008;371:483–91.
11. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008;82:139–49.
12. Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 2008;6:e107.
13. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009;41:56–65.
14. Nakayama K, Bayasgalan T, Yamanaka K, Kumada M, Gotoh T, Utsumi N, et al. Large scale replication analysis of loci associated with lipid concentrations in a Japanese population. J Med Genet. 2009;46:370–4.
15. Muendlein A, Geller-Rhomberg S, Saely CH, Winder T, Sonderegger G, Rein P, et al. Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis. Atherosclerosis. 2009;206:494–9.
16. Shirts BH, Hasstedt SJ, Hopkins PN, Hunt SC. Evaluation of the gene–age interactions in HDL cholesterol, LDL cholesterol, and triglyceride levels: the impact of the SORT1 polymorphism on LDL cholesterol levels is age dependent. Atherosclerosis. 2011;217:139–41.
17. Devaney JM, Thompson PD, Visich PS, Saltarelli WA, Gordon PM, Orkunoglu-Suer EF, et al. The 1p13.3 LDL (C)-associated locus shows large effect sizes in young populations. Pediatr Res. 2011;69:538–43.
18. Angelakopoulou A, Shah T, Sofat R, Shah S, Berry DJ, Cooper J, et al. Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: cardiovascular biomarker genetics collaboration. Eur Heart J. 2012;33:393–407.
19. Adeyemo A, Bentley AR, Meilleur KG, Doumatey AP, Chen G, Zhou J, et al. Transferability and fine mapping of genome-wide associated loci for lipids in African Americans. BMC Med Genet. 2012;13:88.
20. Braun TR, Been LF, Singhal A, Worsham J, Ralhan S, Wander GS, et al. A replication study of GWAS-derived lipid genes in Asian Indians: the chromosomal region 11q23.3 harbors loci contributing to triglycerides. PLoS ONE. 2012;7:e37056.
21. Arvind P, Nair J, Jambunathan S, Kakkar VV, Shanker J. CELSR2-PSRC1-SORT1 gene expression and association with coronary artery disease and plasma lipid levels in an Asian Indian cohort. J Cardiol. 2014;64:339–46.
22. Lee J-Y, Lee B-S, Shin D-J, Woo Park K, Shin Y-A, Joong Kim K, et al. A genome-wide association study of a coronary artery disease risk variant. J Hum Genet. 2013;58:120–6.
23. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161–9.
24. Myocardial Infarction Genetics Consortium, Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009;41:334–41.
25. Wang AZ, Li L, Zhang B, Shen G-Q, Wang QK. Association of SNP rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American caucasian population. Ann Hum Genet. 2011;75:475–82.
26. Jones GT, Bown MJ, Gretarsdottir S, Romaine SPR, Helgadottir A, Yu G, et al. A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet. 2013;22:2941–7.
27. O’Donnell CJ, Kavousi M, Smith AV, Kardia SLR, Feitosa MF, Hwang S-J, et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation. 2011;124:2855–64.
28. Mortensen MB, Kjolby M, Gunnersen S, Larsen JV, Palmfeldt J, Falk E, et al. Targeting sortilin in immune cells reduces proinflammatory cytokines and atherosclerosis. J Clin Investig. 2014;124:5317–22. First paper to show that lack of sortilin in bone marrow derived cells alone (e.g., T-cells and macrophages) attenuates the development of atherosclerosis.
29. Smith JG, Luk K, Schulz C-A, Engert JC, Do R, Hindy G, et al. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA. 2014;312:1764–71.
30. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature. 2004;427:843–8.
31. Jansen P, Giehl K, Nyengaard JR, Teng K, Lioubinski O, Sjoegaard SS, et al. Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat Neurosci. 2007;10:1449–57.
32. Shi J, Kandror KV. Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes. Dev Cell. 2005;9:99–108.
33. Wahe A, Kasmapour B, Schmaderer C, Liebl D, Sandhoff K, Nykjaer A, et al. Golgi-to-phagosome transport of acid sphingomyelinase and prosaposin is mediated by sortilin. J Cell Sci. 2010;123:2502–11.
34. Herda S, Raczkowski F, Mittrücker H-W, Willimsky G, Gerlach K, Kühl AA, et al. The sorting receptor Sortilin exhibits a dual function in exocytic trafficking of interferon-γ and granzyme A in T cells. Immunity. 2012;37:854–66.
35. Quistgaard EM, Madsen P, Groftehauge MK, Nissen P, Petersen CM, Thirup SS. Ligands bind to Sortilin in the tunnel of a ten-bladed beta-propeller domain. Nat Struct Mol Biol. 2009;16:96–8.
36. Quistgaard EM, Grøftehauge MK, Madsen P, Pallesen LT, Christensen B, Sørensen ES, et al. Revisiting the structure of the Vps10 domain of human sortilin and its interaction with neurotensin. Protein Sci. 2014;23:1291–300.
37. Nielsen MS, Jacobsen C, Olivecrona G, Gliemann J, Petersen CM. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem. 1999;274:8832–6.
38. Nilsson SK, Christensen S, Raarup MK, Ryan RO, Nielsen MS, Olivecrona G. Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J Biol Chem. 2008;283:25920–7.
39. Carlo A-S, Gustafsen C, Mastrobuoni G, Nielsen MS, Burgert T, Hartl D, et al. The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-β peptide in the brain. J Neurosci. 2013;33:358–70.
40. Baltes J, Larsen JV, Radhakrishnan K, Geumann C, Kratzke M, Petersen CM, et al. σ1B adaptin regulates adipogenesis by mediating the sorting of sortilin in adipose tissue. J Cell Sci. 2014;127:3477–87.
41. Larsen JV, Hansen M, Moller B, Madsen P, Scheller J, Nielsen M, et al. Sortilin facilitates signaling of ciliary neurotrophic factor and related helical type 1 cytokines targeting the gp130/leukemia inhibitory factor receptor beta heterodimer. Mol Cell Biol. 2010;30:4175–87.
42. Hu F, Padukkavidana T, Vaegter CB, Brady OA, Zheng Y, Mackenzie IR, et al. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron. 2010;68:654–67.
43. Nielsen MS, Madsen P, Christensen EI, Nykjaer A, Gliemann J, Kasper D, et al. The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. EMBO J. 2001;20:2180–90.
44. Cramer JF, Gustafsen C, Behrens MA, Oliveira CLP, Pedersen JS, Madsen P, et al. GGA autoinhibition revisited. Traffic. 2010;11:259–73.
45. Kim E, Lee Y, Lee H-J, Kim JS, Song B-S, Huh J-W, et al. Implication of mouse Vps26b-Vps29-Vps35 retromer complex in sortilin trafficking. Biochem Biophys Res Commun. 2010;403:167–71.
46. Canuel M, Lefrancois S, Zeng J, Morales CR. AP-1 and retromer play opposite roles in the trafficking of sortilin between the Golgi apparatus and the lysosomes. Biochem Biophys Res Commun. 2008;366:724–30.
47. Finan GM, Okada H, Kim T-W. BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin. J Biol Chem. 2011;286:12602–16.
48. Progida C, Nielsen MS, Koster G, Bucci C, Bakke O. Dynamics of Rab7b-dependent transport of sorting receptors. Traffic. 2012;13:1273–85.
49. Tauris J, Ellgaard L, Jacobsen C, Nielsen MS, Madsen P, Thøgersen HC, et al. The carboxy-terminal domain of the receptor-associated protein binds to the Vps10p domain of sortilin. FEBS Lett. 1998;429:27–30.
50. Mazella J, Zsürger N, Navarro V, Chabry J, Kaghad M, Caput D, et al. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem. 1998;273:26273–6.
51. Munck Petersen C, Nielsen MS, Jacobsen C, Tauris J, Jacobsen L, Gliemann J, et al. Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding. EMBO J. 1999;18:595–604.
52. Lefrancois S, Zeng J, Hassan AJ, Canuel M, Morales CR. The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin. EMBO J. 2003;22:6430–7.
53. Klinger SC, Glerup S, Raarup MK, Mari MC, Nyegaard M, Koster G, et al. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking. J Cell Sci. 2011 ed. 2011.
54. Rabinowich L, Fishman S, Hubel E, Thurm T, Park W-J, Pewzner-Jung Y, et al. Sortilin deficiency improves the metabolic phenotype and reduces hepatic steatosis of mice subjected to diet-induced obesity. J Hepatol. 2015;62:175–81. Independent group investigating the full Sort1 KO mice (Exon 14 targeted), and find lower TG content in liver, as well as lower expression of Fas and Scd – genes involved in lipogenesis.
55. Han S, Liang C-P, Westerterp M, Senokuchi T, Welch CL, Wang Q, et al. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J Clin Investig. 2009;119:1029–41.
56. Kjolby M. Sortilins in cardiovascular disease and diabetes. Aarhus University; 2011.
57. Li J, Bi L, Hulke M, Li T. Fish oil and fenofibrate prevented phosphorylation-dependent hepatic sortilin 1 degradation in Western diet-fed mice. J Biol Chem. 2014;289:22437–49. Paper show that sortilin is expression in liver is affected by fish oils and fenofibrates. They also demonstrate regulated phosphorylation on cytoplasmic domain, which impacts sortilin turnover.
58. Bi L, Chiang JYL, Ding W-X, Dunn W, Roberts B, Li T. Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. J Lipid Res. 2013;54:2754–62. In this paper it is shown that ceramide and palmitate directly affect sortilin expression in hepatic cell lines.
59. Zeng J, Racicott J, Morales CR. The inactivation of the sortilin gene leads to a partial disruption of prosaposin trafficking to the lysosomes. Exp Cell Res. 2009;315:3112–24.
60. Ai D, Baez JM, Jiang H, Conlon DM, Hernandez-Ono A, Frank-Kamenetsky M, et al. Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. J Clin Invest. 2012;122:1677–87. In this paper, a novel transcription factor is identified that partly regulates sortilin expression levels. There are also indications that diet influence sortilin expression in the liver.
61. Strong A, Ding Q, Edmondson AC, Millar JS, Sachs KV, Li X, et al. Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism. J Clin Investig. 2012;122:2807–16. In this paper the LDL-catabolism is investigated in WT and Sort1 KO mice. Even though there is an apparant slower catabolism in Sort1 KO mice, they still exhibit lower plasma cholesterol and LDL-C levels, when compared to WT mice.
62. Patel KM, Strong A, Rader DJ. The liver-specific role of sortilin in VLDL secretion. Arterioscler Thromb Vasc Biol Am Heart Assoc. 2013;33:A444.
63. Linsel-Nitschke P, Heeren J, Aherrahrou Z, Bruse P, Gieger C, Illig T, et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis. 2010;208:183–9.
64. Tveten K, Strøm TB, Cameron J, Berge KE, Leren TP. Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia. Atherosclerosis. 2012;225:370–5.
65. Canuel M, Sun X, Asselin M-C, Paramithiotis E, Prat A, Seidah NG. Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1). PLoS ONE. 2013;8:e64145.
66. Roubtsova A, Munkonda MN, Awan Z, Marcinkiewicz J, Chamberland A, Lazure C, et al. Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue. Arterioscler Thromb Vasc Biol. 2011;31:785–91.
67. Leren TP. Sorting an LDL receptor with bound PCSK9 to intracellular degradation. Atherosclerosis. 2014;237:76–81.
68. Klingenberg R, Gerdes N, Badeau RM, Gisterå A, Strodthoff D, Ketelhuth DFJ, et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Investig. 2013;123:1323–34.